Kalium Chloratum Léčiva

Potassium Chloride, the active ingredient in Kalium Chloratum Léčiva, is an electrolyte / potassium supplement presented as a solution for injection for intravenous use. It treats hypokalemia and provides potassium replacement therapy in patients who need electrolyte replenishment.

GNH USA supplies Kalium Chloratum Léčiva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Kalium Chloratum Léčiva is used to correct low potassium levels and support electrolyte balance in clinical settings. - Hypokalemia: restores serum potassium to normal ranges. - Potassium replacement therapy: maintains electrolyte homeostasis during diuretic or postoperative care. - Cardiac arrhythmia risk reduction: helps prevent arrhythmias associated with potassium deficiency.

Kalium Chloratum Léčiva may cause adverse reactions ranging from mild to severe.

Common Side Effects: - Injection site pain or erythema. - Mild hyperkalemia symptoms such as nausea. - Dizziness or headache. - Transient hypotension.

Serious or Rare Side Effects: - Severe hyperkalemia leading to cardiac arrest. - Life‑threatening arrhythmias. - Anaphylactic reaction. - Thrombophlebitis at the infusion site. - Severe hypotension requiring intervention.

When using Kalium Chloratum Léčiva, clinicians should consider several safety measures. - Renal impairment: monitor serum potassium closely. - Cardiac disease: watch for arrhythmias. - Concomitant potassium‑sparing diuretics: increased risk of hyperkalemia. - ACE inhibitors or ARBs: potential additive potassium elevation. - Pediatric use: limited data, use with caution. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Potassium Chloride can interact with other medications, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - ACE inhibitors or ARBs: may cause dangerous hyperkalemia. - Potassium‑sparing diuretics (e.g., spironolactone): risk of severe hyperkalemia. - NSAIDs: can impair renal potassium excretion.

Moderate Interactions (Monitor Closely): - Digoxin: altered cardiac conduction with high potassium. - Beta‑blockers: may mask signs of hyperkalemia. - Insulin or glucose therapy: shifts potassium intracellularly, affecting serum levels.